Board of Pharmacy Dr. Jewell Reddick Confirmation Resolution of 2026
Summary
This resolution confirms Dr. Jewell Reddick as a pharmacist licensed in the District and appoints him to the District of Columbia Board of Pharmacy. The appointment fills a vacant seat formerly held by Ashley Parker Bow and is for the remainder of the unexpired term ending March 12, 2028. The measure is a standard Council confirmation resolution, effective immediately upon adoption, and also directs that copies be transmitted to the nominee and the Mayor’s Office.
The bill does not change substantive pharmacy law or regulatory standards. Instead, it implements the existing appointment authority under the District of Columbia Health Occupations Revision Act of 1985 and the Confirmation Act of 1978 by filling a board vacancy. Its practical effect is to restore full membership to the Board of Pharmacy, which helps maintain oversight of pharmacy licensing, professional regulation, and related public health functions in the District.
Impact
The resolution affects District governance by confirming a new member to the Board of Pharmacy, the body responsible for pharmacy-related oversight under D.C. law. It does not amend the Health Occupations Revision Act or alter licensing requirements, but it does ensure the Board can continue operating with a complete membership and a licensed pharmacist representative. The immediate legal effect is limited to the appointment itself and the completion of the confirmation process for the unexpired term.
Sentiment
The available materials suggest a routine and favorable sentiment toward the nomination. The Mayor formally requested early Council consideration, and the Office of the General Counsel reviewed the resolutions and found them legally unobjectionable. No committee transcript or recorded vote is included, and there is no indication of opposition in the provided record. Overall, the nomination appears to have been treated as a standard professional appointment rather than a controversial policy measure.
Contention
There are no notable substantive points of contention in the provided materials. The only potentially relevant issue is the filling of a vacant seat on the Board of Pharmacy, but the record does not show disagreement over the nominee, the appointment process, or the Board’s role. Because no committee discussion or vote history is included, there is no evidence of debate about qualifications, representation, or regulatory policy.